A high-salt diet may impair cognitive function by causing a deficiency of nitric oxide, which is vital for maintaining vascular health in the brain, according to a new study from Weill Cornell Medicine.
News
Universal flu vaccine developed at Cornell nearing human trials
A universal influenza vaccine developed with the potential to be longer lasting and more effective than commercially available vaccines is destined for human clinical trials, thanks to a $17.9 million grant from the National Institute of Allergy and Infectious Diseases.
Immunology a theme of Intercampus Cancer Symposium
The second annual Intercampus Cancer Symposium, Oct. 11 at the Cornell College of Veterinary Medicine, will highlight the wide range of cancer research taking place at Cornell’s Ithaca campus and at Weill Cornell Medicine in New York City. The many links between immunology and cancer will be a theme of this year’s symposium.
Fall 2019 Newsletter
The Center for Immunology has been busy since it’s launch in March of 2019 and has several great opportunities planned for the future. Center membership has grown tremendously and boasts 260 members from 27 departments in 6 Cornell colleges who bring complementary expertise to our community.
Visit by esteemed immunologist launches new center
To help launch the Cornell Center for Immunology, world-renowned immunologist Mark Davis traveled Cornell University in early September to to give a talk and meet faculty and students. He attended a luncheon for postdoctoral researchers and graduate students from a variety of fields including four who are participants in the National Institutes of Health T32 Training Grant.|
Renowned Immunologist Mark Davis to visit campus
Stanford University Immunologist Dr. Mark M. Davis has been selected as a Fall 2019 University Lecturer. His lecture, “Standing on the Shoulders of Mice: Rebooting Human Immunology” will take place on Monday, September 9 at 4:00pm in Lecture Hall 4/5, College of Veterinary Medicine. This lecture is free and open to the public.
Viral co-infection results in higher pathogenic potential for Nipah and Hendra
The latest edition of the Journal of Virology featured a study by Hector Aguilar-Carreno details how two highly lethal viruses, Nipah and Hendra, have greater pathogenic potential when their cell-sabotaging proteins are combined. Aguilar-Carreno’s lab is also working on related research that may lead to vaccine-free therapies or improved vaccines to treat enveloped viruses, which include infectious diseases such as HIV and influenza.
Sonnenburg Receives Inaugural Cancer Research Institute STAR Award
The Cancer Research Institute’s “Lloyd J. Old Scientists Taking Risks (STAR) program” recognizes immunologists who are conducting high-risk, high-reward research in tumor immunology. Dr. Gregory Sonnenberg is one of five scientists to receive a $1.25 million, five-year grant, to explore disruptive and uncommon cancer research paths following an international competition.
Pediatric Rheumatologist featured in faculty spotlight
Pediatric Rheumatologist Virginia Pascual, Drukier Director of the Gale and Ira Drukier Institute for Children’s Health at Weill Cornell Medicine, is featured in featured in the May 2019 EZRA faculty spotlight.
Discovery reveals potential pathway for treating obesity
A molecule that helps prevent fat accumulation in mammals is produced within fat tissues by stem-like cells that may be therapeutic targets for obesity and related disorders, according to a new study. Obesity increases the risk of other major diseases including cancers, heart disease, diabetes and immunological disorders.
